| Literature DB >> 35647113 |
Yu-Pei Yang1, Shuang-Jun Pan2, Shu-Lin Qiu3, Tao-Hsin Tung4.
Abstract
BACKGROUND: Annually, there are an estimated 1187000 new patients worldwide diagnosed with haematological malignancies. Effective strategies are needed to alleviate side effects and prevent the physical and psychosocial degeneration of patients in active treatment for haematological malignancies. AIM: To explore the effects of physical exercise on quality of life (QoL) of patients with haematological malignancies and thrombocytopenia.Entities:
Keywords: Exercise; Haematological malignancies; Meta-analysis; Quality-of-life; Systematic review; Thrombocytopenia
Year: 2022 PMID: 35647113 PMCID: PMC9082692 DOI: 10.12998/wjcc.v10.i10.3143
Source DB: PubMed Journal: World J Clin Cases ISSN: 2307-8960 Impact factor: 1.534
Search strategy in Pubmed (similar search run in Cochrane Library and EMBASE)
|
|
|
| Hematologic malignancy | Title/Abstract |
| Hematologic malignancies | Title/Abstract |
| Hematological malignancy | Title/Abstract |
| Hematological malignancies | Title/Abstract |
| Hematopoietic malignancies | Title/Abstract |
| Hematopoietic malignancy | Title/Abstract |
| Haematological cancer | Title/Abstract |
| Hematologic cancer | Title/Abstract |
| Hematopoietic cancer | Title/Abstract |
| Leukaemia | Title/Abstract |
| Leukemia | Title/Abstract |
| Myeloma | Title/Abstract |
| Lymphoma | Title/Abstract |
| Hematopoietic stem cell transplantation | Title/Abstract |
| 1 OR 2 OR 3 OR 4 OR 5 OR 6 OR 7 OR 8 OR 9 OR 10 OR 11 OR 12 OR 13 OR 14 | |
| Aerobic exercises | All fields |
| Resistance exercises | All fields |
| Physical exercises | All fields |
| Exercise intervention | All fields |
| Physical activity | All fields |
| 16 OR 17 OR 18 OR 19 OR 20 | |
| Quality of life | Title/Abstract |
| 15 AND 21 AND 22 |
Figure 1PRISMA diagram of study screening and selection. RCT: Randomized controlled trial.
Characteristics of randomized controlled trial
|
|
|
|
|
|
|
|
|
| Jarden | 2009 | Copenhagen | Control: Eoutine care | 16 | Adult patients scheduled for a myeloablative allo-HSCT platelets > 20 × 109/L | 6 mo | Quality of life (EORTC QLQ-C30): (1) At 3 mo, case (65.1 ± 15.9) |
| Experimental: Stretching exercises; resistance training; relaxation and psychoeducation | 13 | ||||||
| Baumann | 2010 | Germany | Control: Routine care | 25 | Adult patients with the indication of an HSCT platelets > 30 × 109/L | The entire hospitalization phase | Quality of life (EORTC QLQ-C30): Case (61.2 ± 22.8) |
| Experimental: Aerobic endurance, training and ADL-training | 24 | ||||||
| Baumann | 2011 | Germany | Control: Routine care | 16 | Adult patients undergoing an allo-HSCT platelets > 10 × 109/L | The whole inpatient time | Quality of life (EORTC QLQ-C30): Case (68.6± 11.2) |
| Experimental: Aerobic endurance, training and ADL-training, interval training, resistance training | 17 | ||||||
| Oechsle | 2014 | Germany | Control: Routine care | 24 | Adult patients with acute myeloid leukemia platelets > 20 × 109/L | During the hospitalization 21 d (range: 16-33 d) | Quality of life (EORTC QLQ-C30): Case 50 |
| Experimental: Endurance training, resistance exercises | 24 | ||||||
| Bryant | 2018 | United States | Control: Routine care | 9 | Adult newly diagnosed with acute leukemia platelets > 10 × 109/L | During the hospitalization | PROMIS short form measures, self-reported measures of HRQOL |
| Experimental:Aerobic training, resistance training | 8 | ||||||
| Wehrle | 2019 | Germany | Control: Routine care | 8 | Adult patients diagnosed with AL platelets > 10 × 109/L | During induction chemotherapy | Quality of life (EORTC QLQ-C30): Case 1 62.5 (45.8-70.8) case 2 50.0 (33.3-58.3); |
| Experimental 1: Aerobic training | 8 | ||||||
| Experimental 2: Resistance training | 6 | ||||||
| Pahl | 2020 | Germany | Control: Routine care | 23 | Adult patients during allo-HSCT, platelets > 20 × 109/L | During the hospitalization | After hospitalization, CG patients reported reduced QoL ( |
QoL: Quality of life; PROMIS: Patient-Reported Outcomes Measurement Information System; allo-HSCT: Allogeneic hematopoietic stem cell transplant; ADL: Activities of daily living; AL: Acute leukemia; WBV: Whole body vibration; CG: Control group; IG: Intervention group; EORTC QLQ-C30: European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30; HRQOL: Health-related quality of life.
Figure 2Risk of bias summary.
Figure 3Meta-analysis result of European Organization for Research and Treatment of Cancer Quality of Life Questionnaire C30. CI: Confidence interval.
Figure 4The Quality of Life Questionnaire C30 results. A: Physical function domain; B: Role functioning domain; C: Emotional functioning domain; D: Cognitive functioning domain; E: Social functioning domain; F: Fatigue domain; G: Nausea and vomiting domain; H: Pain domain; I: Dyspnea domain; J: Insomnia domain; K: Appetite loss domain; L: Constipation domain; M: Diarrhea domain. CI: Confidence interval.